autologous CD8+ melanoma-specific T cells
Term · Oncology and biomedicine · MLC-T-ONC-011565
Autologous CD8 T lymphocytes against melanoma-associated antigens, with potential immunomodulating and antineoplastic activities. Following leukapheresis and the ex vivo expansion of cytotoxic T-lymphocytes, the autologous CD8+ melanoma-specific T cells are re-introduced into the melanoma patient. These cytotoxic T-cells recognize and kill the patient's own melanoma cells.
| Identifier | MLC-T-ONC-011565 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | autologous melanoma-specific cytotoxic T lymphocytes |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-011565",
"term": "autologous CD8+ melanoma-specific T cells",
"field": "Oncology and biomedicine",
"definition": "Autologous CD8 T lymphocytes against melanoma-associated antigens, with potential immunomodulating and antineoplastic activities. Following leukapheresis and the ex vivo expansion of cytotoxic T-lymphocytes, the autologous CD8+ melanoma-specific T cells are re-introduced into the melanoma patient. These cytotoxic T-cells recognize and kill the patient's own melanoma cells.",
"synonyms": [
"autologous melanoma-specific cytotoxic T lymphocytes"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/autologous-cd8-plus-melanoma-specific-t-cells/"
}
Record 2,899 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.